Illness Perceptions and Quality of Life in Patients with Non-Small-Cell Lung Cancer: A 3-Month Follow-Up Pilot Study

被引:9
|
作者
Vollmann, Manja [1 ]
Matsuda, Ayako [2 ]
Kroep, Judith R. [3 ]
Kobayashi, Kunihiko [4 ]
Kubota, Kaoru [5 ]
Inoue, Kenichi [6 ]
Yamaoka, Kazue [7 ]
Putter, Hein [8 ]
Ramai, Rajen [9 ]
Nortier, Hans W. R. [3 ]
Fischer, Maarten J. [10 ]
Kaptein, Ad A. [10 ]
机构
[1] Erasmus Univ, Sociomed Sci ESHPM, Rotterdam, Netherlands
[2] Teikyo Univ, Dept Hyg & Publ Hlth, Sch Med, Tokyo, Japan
[3] Leiden Univ, Med Oncol, Med Ctr, Leiden, Netherlands
[4] Saitama Int Med Ctr, Saitama, Japan
[5] Nippon Med Coll Hosp, Tokyo, Japan
[6] Saitama Canc Ctr, Saitama, Japan
[7] Teikyo Univ, Grad Sch Publ Hlth, Tokyo, Japan
[8] Leiden Univ, Med Stat & Bioinformat, Med Ctr, Leiden, Netherlands
[9] Leiden Univ, Resp Med, Med Ctr, Leiden, Netherlands
[10] Leiden Univ, Med Psychol, Med Ctr, Leiden, Netherlands
来源
关键词
lung cancer; illness perceptions; quality of life; longitudinal design; patient reported outcomes; COMMON-SENSE MODEL; INFORMATION NEEDS; METAANALYSIS; SURVIVAL;
D O I
10.2147/PROM.S238009
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Purpose: Examine illness perceptions, functional health and quality of life of lung cancer patients throughout chemotherapy treatment. Patients and Methods: Longitudinal design with baseline measure 12 days after the first chemotherapy and follow-up measure 3 months later, where illness perceptions (BIPQ), functional health, and quality of life (EORTC QLQ-C-30) were measured. A total of 21 patients with non-small-cell lung cancer took part. Non-parametric testing was performed given the pilot nature of the study and the associated relatively small sample size. Results: Small to medium changes in illness perceptions and functional health between the two measurement points were detected, with both becoming more positive. More negative illness perceptions at the beginning of the treatment were associated with less functioning and lower quality of life at both beginning and end of treatment. Conclusion: Addressing illness perceptions seems a clinically relevant approach in improving functioning and quality of life of patients with non-small-cell lung cancer.
引用
收藏
页码:67 / 71
页数:5
相关论文
共 50 条
  • [41] Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    D'Addario, G.
    Frueh, M.
    Reck, M.
    Baumann, P.
    Klepetko, W.
    Felip, E.
    ANNALS OF ONCOLOGY, 2010, 21 : v116 - v119
  • [42] ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of non-small-cell lung cancer (NSCLC)
    Felip, E
    ANNALS OF ONCOLOGY, 2001, 12 (08) : 1049 - 1050
  • [43] ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of non-small-cell lung cancer (NSCLC)
    Felip, E
    Stahel, RA
    Pavlidis, N
    ANNALS OF ONCOLOGY, 2005, 16 : 28 - 29
  • [44] Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Novello, S.
    Barlesi, F.
    Califano, R.
    Cufer, T.
    Ekman, S.
    Levra, M. Giaj
    Kerr, K.
    Popat, S.
    Reck, M.
    Senan, S.
    Simo, G. V.
    Vansteenkiste, J.
    Peters, S.
    ANNALS OF ONCOLOGY, 2016, 27 : v1 - v27
  • [45] Efficacy of Clozapine in Patients with Schizophrenia - A 3-Month follow-up Study from North India
    Singh, Paramvir
    Singh, Yesh Chandra
    Pandey, Abhinav
    Singh, Chitrakshee
    Muchhala, Nirali
    Karia, Sagar
    ANNALS OF INDIAN PSYCHIATRY, 2023, 7 (03) : 203 - 206
  • [46] Continued smoking after successful treatment in patients with resectable non-small cell lung cancer: A 12-month follow-up study
    Mikami, I
    Akizuki, N
    Akechi, T
    Yamawaki, S
    Uchitomi, S
    PSYCHO-ONCOLOGY, 2004, 13 (08) : S88 - S89
  • [47] Quality of life with durvalumab in stage III non-small-cell lung cancer
    Anota, Amelie
    Westeel, Virginie
    LANCET ONCOLOGY, 2019, 20 (12): : 1619 - 1620
  • [48] A pilot study of concurrent chemotherapy (teniposide and carboplatin) combined with whole brain radiotherapy in non-small-cell lung cancer patients with brain metastases - 4-year follow-up
    Kowalski, DM
    Krzakowski, M
    Jaskiewicz, P
    Wierzchowski, M
    Denisso, T
    Lasota, W
    Zajda, K
    Glogowski, M
    LUNG CANCER, 2004, 45 : S60 - S60
  • [49] Long Follow up from Phase I Study of Nivolumab and Chemotherapy in Patients with Advanced Non-Small-Cell Lung Cancer
    Kanda, S.
    Ohe, Y.
    Matsumoto, Y.
    Murakami, S.
    Goto, Y.
    Horinouchi, H.
    Fujiwara, Y.
    Nokihara, H.
    Yamamoto, N.
    Yamamoto, T.
    Tamura, T.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2419 - S2419
  • [50] Prevalence and risk factors of PTSD symptoms: a 3-month follow-up study
    Shang, Zhilei
    Pan, Xiao
    Cheng, Suhui
    Yang, Yuchen
    Yan, Wenjie
    Sun, Liangliang
    Huang, Hai
    Bai, Yonghai
    Xie, Weifen
    Xu, Shu
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2024, 14